AU2002228660A1 - Use of amidoamines to treat or prevent acanthamoeba and fungal infections - Google Patents

Use of amidoamines to treat or prevent acanthamoeba and fungal infections

Info

Publication number
AU2002228660A1
AU2002228660A1 AU2002228660A AU2866002A AU2002228660A1 AU 2002228660 A1 AU2002228660 A1 AU 2002228660A1 AU 2002228660 A AU2002228660 A AU 2002228660A AU 2866002 A AU2866002 A AU 2866002A AU 2002228660 A1 AU2002228660 A1 AU 2002228660A1
Authority
AU
Australia
Prior art keywords
acanthamoeba
amidoamines
treat
prevent
fungal infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002228660A
Inventor
Sally L. Buck
Nissanke L Dassanayake
Ruth Ann Rosenthal
Ronald L. Schlitzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Inc
Original Assignee
Alcon Universal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Universal Ltd filed Critical Alcon Universal Ltd
Publication of AU2002228660A1 publication Critical patent/AU2002228660A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2002228660A 2000-12-20 2001-11-27 Use of amidoamines to treat or prevent acanthamoeba and fungal infections Abandoned AU2002228660A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25757200P 2000-12-20 2000-12-20
US60/257,572 2000-12-20
PCT/US2001/044408 WO2002049633A2 (en) 2000-12-20 2001-11-27 Use of amidoamines to treat or prevent acanthamoeba and fungal infections

Publications (1)

Publication Number Publication Date
AU2002228660A1 true AU2002228660A1 (en) 2002-07-01

Family

ID=22976832

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002228660A Abandoned AU2002228660A1 (en) 2000-12-20 2001-11-27 Use of amidoamines to treat or prevent acanthamoeba and fungal infections

Country Status (3)

Country Link
US (1) US7025958B2 (en)
AU (1) AU2002228660A1 (en)
WO (1) WO2002049633A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033208A1 (en) * 2000-12-20 2004-02-19 Cagle Gerald D. Antifungal compositions containing an antibiotic and one or more amidoamines
US20070264226A1 (en) * 2006-05-10 2007-11-15 Karagoezian Hampar L Synergistically enhanced disinfecting solutions
US8691899B2 (en) * 2007-10-09 2014-04-08 Ethicon, Inc. Antimicrobial polymer compositions and the use thereof
US8163684B2 (en) * 2008-03-26 2012-04-24 Abbott Medical Optics Inc. Antimicrobials having polyquaternary ammoniums and alcohol-bearing amidoamines and methods for their use
DE102008039254A1 (en) * 2008-08-20 2010-02-25 Megainpharm Gmbh Medicament, useful e.g. for treating infectious- and purulent inflammatory diseases of e.g. eyes, comprises benzyl-dimethyl-(3-(myristoylamino)-propyl)-ammonium chloride, dimethyl-(3-(myristoylamino)-propyl)-amine oxide and solvent
US20100120013A1 (en) * 2008-11-07 2010-05-13 Mb Research Laboratories, Inc. Procedure for long term corneal culture
WO2011100994A1 (en) * 2010-02-19 2011-08-25 Megainpharm Gmbh Pharmaceutical comprising myramistin
WO2013135571A1 (en) 2012-03-14 2013-09-19 Orphanidis Pharma Research Gmbh Compositions with enhanced therapeutic efficacy against infective agents of the eye comprising miltefosine and polyhexamethylene biguanide
WO2014058613A1 (en) 2012-10-08 2014-04-17 Bausch & Lomb Incorporated Minimizing biological lipid deposits on contact lenses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393491A (en) * 1993-09-22 1995-02-28 Alcon Laboratories, Inc. Use of amidoamines in ophthalmic compositions
US5631005A (en) * 1994-09-21 1997-05-20 Alcon Laboratories, Inc. Use of amidoamines in ophthalmic compositions
US5573726A (en) * 1993-09-22 1996-11-12 Alcon Laboratories, Inc. Use of amidoamines in ophthalmic compositions
AR020661A1 (en) 1998-09-30 2002-05-22 Alcon Lab Inc A PHARMACEUTICAL COMPOSITION TOPICA OFTALMICA, OTICA OR NASAL AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT

Also Published As

Publication number Publication date
WO2002049633A3 (en) 2003-05-01
WO2002049633A2 (en) 2002-06-27
US7025958B2 (en) 2006-04-11
US20040058924A1 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
AU2001285020A1 (en) P97-active agent conjugates and their methods of use
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
AUPQ877300A0 (en) Topical treatment of skin
AU2001241729A1 (en) Protected forms of pharmacologically active agents and uses therefor
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2002231206A1 (en) Treatment of depression
AUPQ622600A0 (en) Treatment and/or prevention of ocular pain
AU2002364964A1 (en) Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
AU2002228660A1 (en) Use of amidoamines to treat or prevent acanthamoeba and fungal infections
AU2001239846A1 (en) Dsp with dual-mac processor and dual-mac coprocessor
AU2002219804A1 (en) Water-in-oil insect repellent composition and method of application to the skin
AU2001233259A1 (en) Use of desloratadine for treating allergic and inflammatory conditions
AU2001255696A1 (en) Telomerase inhibitors and methods of their use
AU2001252627A1 (en) Polybenzasol fiber and use of the same
AU2001268236A1 (en) Use of aicar and related compounds
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use
AU2001249692A1 (en) Phospholipid scramblases and methods of use thereof
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2001284380A1 (en) Therapeutic and cosmetic uses of heparanases
AU2002322810A1 (en) Application of hair treatments and other formulations
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2001267177A1 (en) Diagnosis and treatment of herpes infections